Sections
1. Investment Snapshot
2. Valuation & Price Target
3. Business & Product Moat
4. Market & Macro
Discussion
Investment Snapshot
Valuation & Price Target
Business & Product Moat
Market & Macro
Discussion
Nasus Pharma Ltd
Investment Snapshot
Symbol
NSRX
IPO Date (Actual)
2025-08-13
Offer Range
$8.00
Shares Offered
1.3M
Total Shares Post-IPO
10.3M
Market Cap
—
Target Price
$00.00Implied Upside vs Midpoint
$00.00Use of Proceeds
—
Valuation & Price Target
████████████████████
Business & Product Moat
████████████████████
Competitor Set
████████████████████Market & Macro
Sector context: Pharmaceutical Preparations
Same-industry IPOs from the last 365 days (as of 2026-06-04). Returns from IPO open price.
Median IPO open → current
-18.4%
win 20% · n=5Median first month
-19.5%
win 20% · n=5| Company | IPO Date | Open → Current | First Month |
|---|---|---|---|
AVLN Avalyn Pharma Inc. | 2026-04-30 | +11.0% | +11.0% |
KLRA Kailera Therapeutics, Inc. | 2026-04-17 | -18.4% | -19.5% |
GENB Generate Biomedicines, Inc. | 2026-02-27 | -3.1% | -14.4% |
CURX Curanex Pharmaceuticals Inc | 2025-08-26 | -92.4% | -83.5% |
PPCB Propanc Biopharma, Inc. | 2025-08-15 | -36.4% | -20.1% |